Insights
What is moving in fitness and medical weight loss right now, and why it puts the gym at the center.
New, April 2026
The FDA approved orforglipron, the first oral GLP-1 that needs no fasting or water timing, alongside oral semaglutide. A daily pill lowers the barrier to starting, which means more of your members will be on treatment, and more of them will need training and protein to keep the results.
Source: Pharmacy Times
The science
Trials put lean-tissue loss on semaglutide near 45% of total weight lost, and around 25% on tirzepatide, without training. Resistance work plus 1.2 to 1.6 g/kg of protein a day cuts that to near zero. That intervention is the gym.
Source: AJMC, GLP-1 therapies 2026
Why it compounds
Every kilogram of muscle lost lowers resting energy use far more than fat does, which makes weight harder to keep off. Preserving lean mass is central to long-term maintenance, and it is exactly what a trainer delivers.
Source: MDPI, Metabolites 2026
External research describes the medication category and the market, not any Local Healthcare program's results.